News & Updates
Filter by Specialty:
Pembrolizumab extends RFS in stage II melanoma
Pembrolizumab extended recurrence-free survival (RFS) in patients with high-risk stage II melanoma who had undergone complete resection, interim analysis results of the phase III KEYNOTE-716 trial showed.
Pembrolizumab extends RFS in stage II melanoma
01 Nov 2021
Bimekizumab maintains skin clearance in patients with plaque psoriasis
Maintenance treatment with bimekizumab achieves complete scalp, palmoplantar, or nail clearance in patients with moderate-to-severe plaque psoriasis, according to two phase III trials presented at EADV 2021.
Bimekizumab maintains skin clearance in patients with plaque psoriasis
22 Oct 2021
Roflumilast cream eases itch burden, severity in chronic plaque psoriasis
In patients with chronic plaque psoriasis, once-daily treatment with roflumilast improved severity and burden of itch compared with vehicle cream, according to results of the phase III DERMIS-1 and DERMIS-2 trials presented at EADV 2021.
Roflumilast cream eases itch burden, severity in chronic plaque psoriasis
19 Oct 2021
Cold atmospheric plasma device eases severity of atopic dermatitis
Use of the cold atmospheric plasma (CAP) device, which generates free radicals through the ionization of air at room temperature, results in significantly improved mild and moderate atopic dermatitis (AD) with no serious safety concerns, a study has shown.